These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2284482)

  • 1. [The treatment of pulmonary tuberculosis in a special hospital. Its evolution from 1948 to 1986].
    García del Palacio JI; Sánchez Hernández I; Palomero Gil A; Montero Rey D
    Rev Clin Esp; 1990; 187(3):115-20. PubMed ID: 2284482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of pulmonary tuberculosis at a specialized hospital from its beginning to the present time. General aspects].
    Palomero Gil A; Sánchez Hernández I; Montero Rey MD; García del Palacio JI
    Rev Clin Esp; 1989 Oct; 185(5):240-5. PubMed ID: 2608982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterium tuberculosis L forms in patients with pulmonary and pleural tuberculosis during antibacterial chemotherapy].
    Osiĭskiĭ IIu; Kotliar KD
    Vrach Delo; 1989 Sep; (9):55-6. PubMed ID: 2514488
    [No Abstract]   [Full Text] [Related]  

  • 6. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
    Kobashi Y; Matsushima T
    Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
    Borchardt J; Kirsten D; Jörres R; Kroeger C; Magnussen H
    Pneumologie; 1996 Jan; 50(1):28-35. PubMed ID: 8774932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of shorter chemotherapy courses for intrathoracic tuberculosis in children].
    Iukhimenko NV
    Probl Tuberk; 2000; (3):20-3. PubMed ID: 10900978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smear-negative pulmonary tuberculosis.
    Dutt AK; Stead WW
    Semin Respir Infect; 1994 Jun; 9(2):113-9. PubMed ID: 7973170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.